Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner
2021 · Acta Pharmaceutica Sinica B · 86 citations
https://doi.org/10.1016/j.apsb.2021.09.007
Y
Yan He
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.0K
Citations
17
h-index
26
i10-index
Yan He is an academic researcher from Nanchang University. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Cardiovascular Function and Risk Factors & Inflammasome and immune disorders. The author has an h-index of 17, co-authored 49 publications.
ORCID: 0000-0002-2402-0255Papers by this author
worksBlockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
2023 · Signal Transduction and Targeted Therapy · 60 citations
https://doi.org/10.1038/s41392-022-01248-9
Liraglutide reduces body weight by upregulation of adenylate cyclase 3
2017 · Nutrition and Diabetes · 27 citations
https://doi.org/10.1038/nutd.2017.17
Associations of different type of physical activity with all-cause mortality in hypertension participants
2024 · Scientific Reports · 9 citations
https://doi.org/10.1038/s41598-024-58197-2
The global burden of high BMI among adolescents between 1990 and 2021
2025 · Communications Medicine · 8 citations
https://doi.org/10.1038/s43856-025-00838-2
Global burden of high sugar-sweetened beverage consumption among young adults
2025 · Diabetology & Metabolic Syndrome · 7 citations
https://doi.org/10.1186/s13098-025-01845-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat